Q&A 2016

In the run up to our highly prestigious 2^nd Annual Cell and Gene Therapy Congress we sat with one of our highly esteemed speakers, Fulvio Mavilio, Scientific Director, Genethon to talk about the most exciting developments in the cell and gene therapy field, the challenges the industry is currently facing, viral vs non-viral vector systems, gene editing and his upcoming talk.

Fulvio Mavilio, Ph.D., is Scientific Director of Genethon (Evry, France), and Professor of Molecular Biology and University of Modena and Reggio Emilia (Modena, Italy). Prof. Mavilio graduated in Biology at the University of Rome in 1976, and obtained a Ph.D. in Medical Genetics in 1979. He is an expert and a pioneer in the fields of gene therapy and stem cell research, and author of over 180 articles in major international journals.

Click here to read our interview with Fulvio Mavilio.

Cell & Gene Therapy and Stem Cells Q & As 2015

Ahead of the Cell & Gene Therapy Congress and 2nd Annual Stem Cell Congress 2015, we spoke to Francesco Saverio Tedesco, Principal Research Associate at University College London on the subject of stem cell differentiation and commercial development.

Francesco Saverio Tedesco
Dr Tedesco obtained his PhD at San Rafaelle Scientific Institute in 2010, where he also published research in the field of human artificial chromosomes.  After his PhD he coupled post-doctoral research in muscle regeneration with clinical practice and training between San Raffaele Hospital and UCL and UCL Hospitals. Dr. Tedesco also became a co-investigator in a first-in-human clinical trial based upon transplantation of donor muscle stem cells for Duchenne muscular dystrophy.
He joined UCL’s Department of Cell and Developmental Biology in 2012 as a Senior Research Associate, and in 2013 he was appointed Principal Research Associate and established an independent research group.

Click here to read out interview with Francesco Saverio Tedesco.